ScreenerHero
SOLVSolventum Corporation
NYSE · US · Healthcare · Medical Instruments & Supplies · solventum.com
88.32USD-0.33%Mkt Cap: 15.08B $P/E: 10.83

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates throug…

Industry Peers

Medical Instruments & Supplies
Screen all
ISRG
Intuitive Surgical, Inc.
$142.49BUSDP/E 45.6
EL
EssilorLuxottica Societe anonyme
$80.53BUSDP/E 30.2
BDX
Becton, Dickinson and Company
$51.10BUSDP/E 32.5
MDLN
Medline Inc. Class A Common Stock
$45.62BUSDP/E 42.4
ALC
Alcon AG
$32.71BUSDP/E 55.9
RMD
ResMed Inc.
$33.27BUSDP/E 22.1
WST
West Pharmaceutical Services, Inc.
$24.90BUSDP/E 45.4
DIM
Sartorius Stedim Biotech
$20.62BUSDP/E 64.6
SRT3
Sartorius Aktiengesellschaft
$18.68BUSDP/E 87.6
STMN
Straumann Holding AG
$17.47BUSDP/E 41.6
SRT
Sartorius Aktiengesellschaft
$15.01BUSDP/E 70.4
COLO-B
Coloplast A/S
$14.31BUSDP/E 35.6
COO
The Cooper Companies, Inc.
$14.85BUSDP/E 64.5
BAX
Baxter International Inc.
$13.77BUSD
ALGN
Align Technology, Inc.
$11.58BUSDP/E 28.3
RGEN
Repligen Corporation
$9.95BUSDP/E 241.6
AVTR
Avantor, Inc.
$9.44BUSD
ATR
AptarGroup, Inc.
$8.45BUSDP/E 24.0
YPSN
Ypsomed Holding AG
$6.15BUSDP/E 25.1
STVN
Stevanato Group S.p.A.
$6.10BUSDP/E 39.2

Key Statistics

Company
Market Cap15.08B $
Enterprise Value19.98B $
Revenue (TTM)8.31B $
Gross Profit4.45B $
Net Income (TTM)1.56B $
Revenue/Share47.79 USD
Last Price88.32 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees20.6K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)10.83
P/E (Forward)12.27
PEG1.22
EV/EBITDA17.54
EV/Revenue2.40
P/S1.82
P/B3.14
EPS (TTM)8.26
EPS (Forward)7.22
52W Range
62.3894% of range90.00
52W High90.00 USD
52W Low62.38 USD
Profitability
Gross Margin53.47%
Oper. Margin9.78%
EBITDA Margin13.71%
Profit Margin18.69%
ROE30.81%
ROA10.89%
Growth
Revenue Growth2.20%
Earnings Growth3.90%
Cash Flow & Leverage
Operating CF369.00M $
CapEx (TTM)379.00M $
FCF Margin5.88%
FCF Yield3.24%
Net Debt4.89B $
Net Debt/EBITDA4.29
Balance Sheet
Debt/Equity1.00
Current Ratio1.02
Quick Ratio0.50
Book Value/Sh28.22 USD
Cash/Share2.367 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.2 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)93.92 USD
Upside (mean)+6.3%
Target Range70.00 USD – 113.00 USD
$70.00+6.3% to mean$113.00
# Analysts13
Ownership
Shares Out.170.22M
Float144.13M
Insiders15.32%
Institutions76.01%
Short Interest
Short Ratio3.3d
Short % Float2.43%
Short % Out.2.06%
Shares Short3.51M
Short (prev mo.)5.02M
Technical
SMA 5080.80 (+9.3%)
SMA 20076.31 (+15.7%)
Beta0.67
S&P 52W Chg18.16%
Avg Vol (30d)883.20K
Avg Vol (10d)1.12M
Technical Indicators
RSI (14)61.6
MACD2.1112
MACD Signal2.0349
MACD Hist.+0.0763
BB Upper92.03 USD
BB Middle85.25 USD
BB Lower78.47 USD
BB Width15.91%
ATR (14)2.801 USD
Vol Ratio (20d)0.66x